Trial Condition(s):
HPA axis study in Japanese adults
15519
Not Available
Not Available
A multicenter, open-label study to evaluate the adrenal suppression potential of Mapracorat 0.1% ointment in Japanese adults with atopic dermatitis.
- Signed written informed consent - Male or female subject aged >= 20 years - Diagnosis of atopic dermatitis according to the Hanifin and Rajka criteria - Investigator's Global Assessment (IGA) score of 3 (moderate) to 4 (severe) at baseline - Normal ACTH response before start of treatment
- Pregnancy or lactation - Clinically relevant disease, which could interfere with the study conduct or the evaluation and interpretation of the study results - Concomitant medical or dermatological disorder(s), which could interfere with the investigator's ability to evaluate the subject's response to the investigational product - Clinically manifest immunosuppressive disorder or known history of malignant disease
Locations | |
---|---|
Locations Kawaguchi Kogyo General Hospital Saitama, Japan | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Clinical Research Hospital Tokyo Tokyo, Japan | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Tokyo Women's Medical University Tokyo, Japan | Contact Us: E-mail: [email protected] Phone: Not Available |
A Multicenter, Open-label Study to Evaluate the Adrenal Suppression Potential of Mapracorat 0.1% Ointment in Japanese Adults With Atopic Dermatitis
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Treatment
Allocation:
N/A
Blinding:
Open Label
Assignment:
Single Group Assignment
Trial Arms:
1